Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2400 of 2873 entries
View as:

Feasibility of Combined Genomics/Transcriptomics for Patients With Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT05464823 Org: User:
Start: 07/07/22 End: 05/12/27 Due: 05/12/28

MK-0646 and Gemcitabine +/- Erlotinib for Patients With Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00769483 Org: User:
Start: 11/13/08 End: 09/01/20 Due: 09/01/21

Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01113476 Org: User:
Start: 04/27/10 End: 08/12/22 Due: 08/12/23

Interleukin-12 in Treating Patients With Cancer in the Abdomen

Phase: N/A Priority: Normal
NCT ID: NCT00003046 Org: User:
Start: 08/31/97 End: 10/31/01 Due: 10/31/02

Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05922930 Org: User:
Start: 10/11/23 End: 01/15/28 Due: 01/15/29

68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03001349 Org: User:
Start: 05/16/17 End: 02/05/21 Due: 02/05/22

Intratumoral Injections of LL37 for Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT02225366 Org: User:
Start: 07/08/15 End: 11/24/20 Due: 11/24/21

BATTLE Program: Umbrella Protocol for Patients With Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00409968 Org: User:
Start: 11/27/06 End: 10/31/19 Due: 10/31/20

Phase I Study of IV DOTAP: Cholesterol-Fus1 in Non-Small-Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00059605 Org: User:
Start: 03/31/03 End: 04/30/11 Due: 04/30/12

Elotuzumab for the Treatment of JAK2-Mutated Myelofibrosis

Phase: N/A Priority: Normal
NCT ID: NCT04517851 Org: User:
Start: 02/10/21 End: 12/31/25 Due: 12/31/26

Pharmacologic Pretransplant Immunosuppression (PTIS) + Reduced Toxicity Conditioning (RTC) Allogeneic Stem Cell Transplantation in Inherited Hematologic Disorders

Phase: N/A Priority: Normal
NCT ID: NCT05293509 Org: User:
Start: 03/02/22 End: 09/18/23 Due: 09/18/24

Clinical Data Collection in Studying Clinical Factors Associated With Post-Surgery Chronic Opioid Use in Patients With Head and Neck Cancers

Phase: N/A Priority: Normal
NCT ID: NCT03888651 Org: User:
Start: 01/25/19 End: 04/30/25 Due: 04/30/26

EON: A Single-arm Phase II Study of Etigilimab (OMP-313M32) in Combination With Checkpoint Inhibition (Nivolumab) in Patients With Platinum-resistant, Recurrent Epithelial Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05715216 Org: User:
Start: 03/24/23 End: 02/08/26 Due: 02/08/27

Questionnaires in Assessing Attitudes About Legalization of Marijuana Use in Participants With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03360799 Org: User:
Start: 11/17/17 End: 08/26/19 Due: 08/26/20

High Flow Oxygen and Bilevel Airway Pressure for Persistent Dyspnea in Patients With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00934128 Org: User:
Start: 08/31/09 End: 11/30/12 Due: 11/30/13

Sorafenib and Thoracic Radiation for Patients With Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00543335 Org: User:
Start: 01/25/08 End: 01/31/11 Due: 01/31/12

R-21 Colorectal Cancer Screening (CRCS) Pilot Trial

Phase: N/A Priority: Normal
NCT ID: NCT01492049 Org: User:
Start: 08/07/12 End: 09/12/18 Due: 09/12/19

Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity Squamous Cell Carcinoma (OCSCC).

Phase: N/A Priority: Normal
NCT ID: NCT06448026 Org: User:
Start: 11/21/24 End: 05/15/27 Due: 05/15/28

Fecal Microbial Transplants for the Treatment of Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04975217 Org: User:
Start: 12/14/21 End: 12/31/26 Due: 12/31/27

Phase Ib Trial of the KRASG12C Inhibitor Adagrasib (MRTX849) in KRAS G12C Mutant Metastatic Pancreatic Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT05634525 Org: User:
Start: 05/03/23 End: 11/01/27 Due: 11/01/28

Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT03214562 Org: User:
Start: 09/26/17 End: 09/30/25 Due: 09/30/26

Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02876107 Org: User:
Start: 10/06/16 End: 10/31/25 Due: 10/31/26

Cryoablation for the Treatment of Metastatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04150939 Org: User:
Start: 12/23/19 End: 08/31/25 Due: 08/31/26

SCH 66336 Before Surgery in Treating Patients With Colorectal Cancer That Has Metastasized to the Liver

Phase: N/A Priority: Normal
NCT ID: NCT00005030 Org: User:
Start: 09/29/99 End: 09/30/00 Due: 09/30/01

Rituximab Maintenance After Autologous Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT01103388 Org: User:
Start: 08/31/03 End: 04/30/10 Due: 04/30/11